Applied Stemcell News Today

MILPITAS, Calif.--(BUSINESS WIRE)--Dec 4, 2023--

Applied StemCell specializes in cell and gene therapy products and services. QHP's investment in the company reflects a history of healthcare and pharma investment.

Rolling one-year VC fund returns fell to -17% in 2022, while VC fundraising is on track to hit a 6-year low by the end of the year.

RALEIGH, N.C. & MILPITAS, Calif., October 09, 2023--QHP Capital Acquires Applied StemCell

/PRNewswire/ -- In the near future, the CRISPR industry is poised to revolutionize various sectors with its unprecedented potential. The widespread adoption...

/PRNewswire/ -- The mice model industry is expected to experience significant growth in the near future as researchers and pharmaceutical companies continue to...

MarkNtel Advisors has released a brand-new research study with a thorough analysis of the CRISPR Gene Editing Market. Stakeholders can profit from the

Global iPSCs Manufacturing Services Market Research Insight 2022| Industry Development – Future Growth Prospects, Revenue Forecast Up to 2030

Global iPSCs Manufacturing Services Market Research Insight 2022

Global CRISPR Gene Editing Market Analysis, Segmentation, Size, Share, Trend, Future Demand and Leading Players Forecast to 2027